BioHarvest Sciences will announce its Q3 2026 financial results on November 12, focusing on its transformation into a CDMO.
| Name | BIOHARVEST SCIENCES INC. |
|---|---|
| CIK | 0001723464 |
| Tickers | BHST |
| Exchanges | Nasdaq |
| Entity type | other |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | A1 British Columbia, Canada |
| Phone | 6046221186 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 0 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
BioHarvest Sciences will announce its Q3 2026 financial results on November 12, focusing on its transformation into a CDMO.
BioHarvest Sciences Inc. shares updates on its progress in the pharmaceutical preparations sector, highlighting its commitment to innovation and growth.
BioHarvest Sciences and Tate & Lyle reach a key milestone in developing next-generation sweeteners, showcasing BioHarvest's innovative Botanical Synthesis platform.
137 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | 6-K | REPORT | 0001723464-26-000064 | 001-42389 | 261541795 | 34 | 544034 | |||
| 2026-10-29 | 6-K | REPORT | 0001723464-26-000062 | 001-42389 | 261502527 | 34 | 23261 | |||
| 2026-10-13 | 6-K | REPORT | 0001723464-26-000060 | 001-42389 | 261457451 | 34 | 34151 | |||
| 2026-10-08 | 6-K | REPORT | 0001723464-26-000058 | 001-42389 | 261449615 | 34 | 40286 | |||
| 2026-10-02 | 6-K | REPORT | 0001723464-26-000056 | 001-42389 | 261432837 | 34 | 26889 | |||
| 2026-09-15 | 6-K | REPORT | 0001723464-26-000054 | 001-42389 | 261381682 | 34 | 24851 | |||
| 2026-09-15 | 6-K | REPORT | 0001723464-26-000052 | 001-42389 | 261381657 | 34 | 26644 | |||
| 2026-09-14 | 6-K | REPORT | 0001723464-26-000050 | 001-42389 | 261378172 | 34 | 23993 | |||
| 2026-09-03 | 6-K | REPORT | 0001723464-26-000048 | 001-42389 | 261358078 | 34 | 28871 | |||
| 2026-08-12 | 6-K | REPORT | 0001723464-26-000046 | 001-42389 | 261264620 | 34 | 143258 | |||
| 2026-08-11 | 6-K | REPORT | 0001723464-26-000044 | 001-42389 | 261259812 | 34 | 538875 | |||
| 2026-07-29 | 6-K | REPORT | 0001723464-26-000042 | 001-42389 | 261217327 | 34 | 23201 | |||
| 2026-07-28 | 6-K | REPORT | 0001723464-26-000040 | 001-42389 | 261210623 | 34 | 23851 | |||
| 2026-07-16 | 6-K | REPORT | 0001723464-26-000038 | 001-42389 | 261178239 | 34 | 27016 | |||
| 2026-07-15 | 6-K | REPORT | 0001723464-26-000036 | 001-42389 | 261177291 | 34 | 28688 | |||
| 2026-06-18 | 6-K | REPORT | 0001723464-26-000034 | 001-42389 | 261102203 | 34 | 24772 | |||
| 2026-05-28 | 6-K | REPORT | 0001723464-26-000032 | 001-42389 | 261029924 | 34 | 2176361 | |||
| 2026-05-14 | 6-K | REPORT | 0001723464-26-000030 | 001-42389 | 26978484 | 34 | 140824 | |||
| 2026-05-14 | 6-K | REPORT | 0001723464-26-000028 | 001-42389 | 26977411 | 34 | 465135 | |||
| 2026-05-14 | 6-K | REPORT | 0001723464-26-000026 | 001-42389 | 26976469 | 34 | 41843 | |||
| 2026-05-13 | 6-K | REPORT | 0001723464-26-000024 | 001-42389 | 26972420 | 34 | 27437 | |||
| 2026-05-12 | 6-K | REPORT | 0001723464-26-000022 | 001-42389 | 26967742 | 34 | 31234 | |||
| 2026-05-11 | 6-K | REPORT | 0001723464-26-000020 | 001-42389 | 26964391 | 34 | 23425 | |||
| 2026-05-01 | 6-K | REPORT | 0001723464-26-000018 | 001-42389 | 26927916 | 34 | 20196 | |||
| 2026-04-29 | 6-K | REPORT | 0001723464-26-000016 | 001-42389 | 26913924 | 34 | 24405 | |||
| 2026-03-31 | 40-F | BIOHARVEST SCIENCES INC. - FORM 40-F SEC FILING | 0001376474-26-000257 | 001-42389 | 26821559 | 34 | 8229161 | 1 | 1 | |
| 2026-03-27 | 6-K | REPORT | 0001723464-26-000014 | 001-42389 | 26805941 | 34 | 28260 | |||
| 2026-03-17 | 6-K | REPORT | 0001723464-26-000012 | 001-42389 | 26761431 | 34 | 23695 | |||
| 2026-03-16 | 6-K | REPORT | 0001723464-26-000010 | 001-42389 | 26755875 | 34 | 23115 | |||
| 2026-03-06 | 6-K | REPORT | 0001723464-26-000008 | 001-42389 | 26731360 | 34 | 21675 | |||
| 2026-03-05 | 6-K | REPORT | 0001723464-26-000006 | 001-42389 | 26725333 | 34 | 52306 | |||
| 2026-03-03 | 6-K | REPORT | 0001723464-26-000004 | 001-42389 | 26713225 | 34 | 22853 | |||
| 2026-01-07 | 6-K | REPORT | 0001723464-26-000002 | 001-42389 | 26515133 | 34 | 79818 | |||
| 2025-12-31 | AW | AMENDMENT WITHDRAWAL REQUEST FOR POS AM | 0001723464-25-000035 | 333-289908 | 251617308 | NE | 5827 | |||
| 2025-12-29 | POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 | 0001723464-25-000033 | 333-289908 | 251608874 | 33 | 284273 | |||
| 2025-12-18 | 6-K | REPORT | 0001723464-25-000031 | 001-42389 | 251583108 | 34 | 23174 | |||
| 2025-12-03 | 6-K | REPORT | 0001723464-25-000029 | 001-42389 | 251546018 | 34 | 173333 | |||
| 2025-11-13 | 6-K | REPORT | 0001723464-25-000027 | 001-42389 | 251478167 | 34 | 512118 | |||
| 2025-11-12 | 6-K | REPORT | 0001723464-25-000025 | 001-42389 | 251472254 | 34 | 22736 | |||
| 2025-11-10 | 6-K | CURRENT REPORT | 0001723464-25-000023 | 001-42389 | 251467518 | 34 | 25205 | |||
| 2025-11-10 | 6-K | REPORT | 0001723464-25-000021 | 001-42389 | 251463885 | 34 | 280333 | |||
| 2025-11-10 | 424B5 | PROSPECTUS SUPPLEMENT | 0001723464-25-000019 | 333-289908 | 251463768 | 33 | 445336 | |||
| 2025-11-06 | 424B7 | PROSPECTUS SUPPLEMENT NO. 3 | 0001723464-25-000017 | 333-289908 | 251458997 | 33 | 446219 | |||
| 2025-11-04 | 6-K | REPORT | 0001723464-25-000015 | 001-42389 | 251448733 | 34 | 50188 | |||
| 2025-10-31 | 6-K | REPORT | 0001723464-25-000013 | 001-42389 | 251440847 | 34 | 95327 | |||
| 2025-10-31 | 6-K | REPORT | 0001723464-25-000011 | 001-42389 | 251439498 | 34 | 34302 | |||
| 2025-10-15 | 424B7 | PROSPECTUS SUPPLEMENT NO. 2 | 0001723464-25-000009 | 333-289908 | 251395693 | 33 | 251035 | |||
| 2025-10-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001723464-25-000007 | 021-559831 | 251375116 | 33 | 17032 | ||
| 2025-09-24 | 424B7 | PROSPECTUS SUPPLEMENT NO. 1 | 0001139020-25-000337 | 333-289908 | 251338920 | 33 | 251752 | |||
| 2025-09-23 | 6-K | REPORT | 0001723464-25-000006 | 001-42389 | 251333500 | 34 | 27278 | |||
| 2025-09-22 | 6-K | REPORT | 0001723464-25-000004 | 001-42389 | 251329789 | 34 | 24475 | |||
| 2025-09-10 | 6-K | REPORT | 0001139020-25-000315 | 001-42389 | 251306144 | 34 | 25077 | |||
| 2025-09-09 | 6-K | REPORT | 0001139020-25-000304 | 001-42389 | 251302618 | 34 | 25362 | |||
| 2025-09-09 | 6-K | REPORT | 0001139020-25-000300 | 001-42389 | 251301077 | 34 | 40357 | |||
| 2025-09-08 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002876 | 333-289908 | 251301571 | 33 | 1928 | ||
| 2025-09-04 | CORRESP | filename1.htm | 0001139020-25-000295 | 5589 | ||||||
| 2025-09-03 | UPLOAD | filename1.pdf | 0000000000-25-009482 | 333-289908 | 40308 | |||||
| 2025-09-02 | 6-K | REPORT | 0001139020-25-000289 | 001-42389 | 251284959 | 34 | 24123 | |||
| 2025-08-28 | DEL AM | DELAYING AMENDMENT | 0001139020-25-000279 | 333-289908 | 251273576 | 33 | 6529 | |||
| 2025-08-28 | F-3 | REGISTRATION STATEMENT | 0001139020-25-000277 | 333-289908 | 251269241 | 33 | 664810 | 1 | 1 | |
| 2025-08-15 | 6-K | REPORT | 0001139020-25-000263 | 001-42389 | 251221592 | 34 | 21366 | |||
| 2025-08-13 | 6-K | REPORT | 0001139020-25-000255 | 001-42389 | 251213090 | 34 | 45683 | |||
| 2025-08-11 | 6-K | REPORT | 0001139020-25-000253 | 001-42389 | 251202497 | 34 | 102809 | |||
| 2025-08-11 | 6-K | REPORT | 0001139020-25-000251 | 001-42389 | 251201934 | 34 | 439447 | |||
| 2025-08-05 | 6-K | REPORT | 0001139020-25-000245 | 001-42389 | 251184332 | 34 | 49995 | |||
| 2025-07-23 | 6-K | REPORT | 0001139020-25-000239 | 001-42389 | 251142780 | 34 | 20900 | |||
| 2025-07-23 | S-8 | REGISTRATION STATEMENT | 0001139020-25-000237 | 333-288882 | 251142398 | 33 | 268094 | |||
| 2025-07-07 | 6-K | REPORT | 0001139020-25-000203 | 001-42389 | 251108071 | 34 | 45654 | |||
| 2025-07-03 | 6-K | REPORT | 0001139020-25-000201 | 001-42389 | 251104143 | 34 | 36292 | |||
| 2025-06-10 | 6-K | REPORT | 0001139020-25-000164 | 001-42389 | 251035370 | 34 | 1507871 | |||
| 2025-06-04 | 6-K | REPORT | 0001139020-25-000158 | 001-42389 | 251022769 | 34 | 26102 | |||
| 2025-05-21 | 6-K | REPORT | 0001139020-25-000141 | 001-42389 | 25972787 | 34 | 25932 | |||
| 2025-05-15 | 6-K | REPORT | 0001139020-25-000128 | 001-42389 | 25954854 | 34 | 128360 | |||
| 2025-05-15 | 6-K | REPORT | 0001139020-25-000126 | 001-42389 | 25953907 | 34 | 454995 | |||
| 2025-05-12 | 6-K | REPORT | 0001139020-25-000113 | 001-42389 | 25935202 | 34 | 25473 | |||
| 2025-05-01 | 6-K | REPORT | 0001139020-25-000095 | 001-42389 | 25902297 | 34 | 25687 | |||
| 2025-04-01 | 6-K | REPORT | 0001139020-25-000019 | 001-42389 | 25797549 | 34 | 636038 | |||
| 2025-04-01 | 6-K | REPORT | 0001139020-25-000016 | 001-42389 | 25795863 | 34 | 141413 | |||
| 2025-03-31 | F-X | APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING | 0001376474-25-000301 | 001-42389 | 25794898 | 33 | 16533 | |||
| 2025-03-31 | 40-F | BIOHARVEST SCIENCES INC. - FORM 40-F SEC FILING | 0001376474-25-000299 | 001-42389 | 25794831 | 34 | 10038741 | 1 | 1 | |
| 2025-03-17 | 6-K | REPORT | 0001393905-25-000118 | 001-42389 | 25744145 | 34 | 24186 | |||
| 2025-03-06 | 6-K | REPORT | 0001393905-25-000095 | 001-42389 | 25714871 | 34 | 22990 | |||
| 2025-03-04 | 6-K | REPORT | 0001393905-25-000085 | 001-42389 | 25702836 | 34 | 29270 | |||
| 2025-02-18 | 6-K | REPORT | 0001393905-25-000067 | 001-42389 | 25634055 | 34 | 25716 | |||
| 2025-02-14 | 6-K | REPORT | 0001393905-25-000063 | 001-42389 | 25626353 | 34 | 24670 | |||
| 2025-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001877291-25-000003 | 005-94858 | 25616177 | 34 | 5780 | |||
| 2025-02-12 | 6-K | REPORT | 0001393905-25-000056 | 001-42389 | 25614507 | 34 | 24391 | |||
| 2025-02-11 | 6-K | REPORT | 0001393905-25-000054 | 001-42389 | 25607243 | 34 | 19659 | |||
| 2025-01-23 | 6-K | REPORT | 0001393905-25-000028 | 001-42389 | 25549467 | 34 | 61975 | |||
| 2025-01-22 | 6-K | REPORT | 0001393905-25-000026 | 001-42389 | 25545475 | 34 | 53222 | |||
| 2025-01-08 | 6-K | REPORT | 0001393905-25-000011 | 001-42389 | 25518090 | 34 | 34364 | |||
| 2024-12-11 | 6-K | REPORT | 0001393905-24-000417 | 001-42389 | 241541192 | 34 | 39919 | |||
| 2024-11-26 | 6-K | REPORT | 0001393905-24-000403 | 001-42389 | 241497412 | 34 | 133258 | |||
| 2024-11-25 | 6-K | REPORT | 0001393905-24-000401 | 001-42389 | 241497174 | 34 | 114349 | |||
| 2024-11-25 | 6-K | REPORT | 0001393905-24-000399 | 001-42389 | 241496870 | 34 | 472982 | |||
| 2024-11-21 | 6-K | REPORT | 0001393905-24-000395 | 001-42389 | 241485473 | 34 | 24285 | |||
| 2024-11-19 | 6-K | REPORT | 0001393905-24-000393 | 001-42389 | 241472775 | 34 | 24599 | |||
| 2024-11-18 | 6-K | REPORT | 0001393905-24-000391 | 001-42389 | 241469353 | 34 | 31964 | |||
| 2024-11-12 | 6-K | REPORT | 0001393905-24-000385 | 001-42389 | 241447342 | 34 | 24503 | |||
| 2024-11-08 | CERT | 8A_Cert_BHST.pdf | 0001354457-24-000857 | 001-42389 | 241441521 | 34 | 245050 | |||
| 2024-11-08 | CERT | BHST_8A_Cert.pdf | 0001354457-24-000856 | 001-42389 | 241441012 | 34 | 247886 | |||
| 2024-11-08 | 6-K | REPORT | 0001393905-24-000380 | 001-42389 | 241438410 | 34 | 41995 | |||
| 2024-10-29 | 6-K | REPORT | 0001393905-24-000365 | 001-42389 | 241402191 | 34 | 42427 | |||
| 2024-10-28 | 6-K | REPORT | 0001393905-24-000363 | 001-42389 | 241400989 | 34 | 33178 | |||
| 2024-10-28 | 8-A12B | REGISTRATION STATEMENT | 0001393905-24-000361 | 001-42389 | 241400041 | 34 | 17544 | |||
| 2024-10-23 | 6-K | REPORT | 0001393905-24-000359 | 000-56663 | 241389578 | 34 | 173366 | |||
| 2024-10-16 | 6-K | REPORT | 0001393905-24-000354 | 000-56663 | 241374140 | 34 | 24748 | |||
| 2024-09-20 | 6-K | REPORT | 0001393905-24-000339 | 000-56663 | 241314217 | 34 | 20600 | |||
| 2024-09-20 | 6-K | REPORT | 0001393905-24-000335 | 000-56663 | 241312617 | 34 | 32934 | |||
| 2024-09-12 | 6-K | REPORT | 0001393905-24-000327 | 000-56663 | 241294857 | 34 | 23122 | |||
| 2024-09-06 | 6-K | REPORT | 0001393905-24-000322 | 000-56663 | 241284336 | 34 | 52186 | |||
| 2024-09-05 | 6-K | REPORT | 0001393905-24-000318 | 000-56663 | 241278989 | 34 | 23265 | |||
| 2024-08-29 | 6-K | REPORT | 0001393905-24-000310 | 000-56663 | 241264126 | 34 | 168743 | |||
| 2024-08-29 | 6-K | REPORT | 0001393905-24-000306 | 000-56663 | 241262414 | 34 | 460575 | |||
| 2024-08-27 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-003646 | 134857 | ||||||
| 2024-08-27 | UPLOAD | filename1.pdf | 0000000000-24-009738 | 000-56663 | 39893 | |||||
| 2024-08-22 | 20FR12G/A | REGISTRATION STATEMENT | 0001393905-24-000304 | 000-56663 | 241231593 | 34 | 2034913 | |||
| 2024-08-21 | UPLOAD | filename1.pdf | 0000000000-24-009566 | 000-56663 | 42443 | |||||
| 2024-08-14 | 20FR12G/A | REGISTRATION STATEMENT | 0001393905-24-000290 | 000-56663 | 241207710 | 34 | 2140577 | |||
| 2024-08-06 | UPLOAD | filename1.pdf | 0000000000-24-008980 | 000-56663 | 45068 | |||||
| 2024-07-24 | 20FR12G/A | REGISTRATION STATEMENT | 0001393905-24-000268 | 000-56663 | 241138010 | 34 | 7371609 | |||
| 2024-07-12 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-003212 | 141540 | ||||||
| 2024-07-10 | UPLOAD | filename1.pdf | 0000000000-24-007803 | 000-56663 | 57983 | |||||
| 2024-06-14 | 20FR12G | REGISTRATION STATEMENT | 0001393905-24-000225 | 000-56663 | 241045597 | 34 | 9920048 | |||
| 2024-01-11 | D | xslFormDX01/primary_doc.xml | 06b | 0001814587-24-000001 | 021-502184 | 24528881 | 33 | 12434 | ||
| 2023-11-21 | D | xslFormDX01/primary_doc.xml | 06b | 0001814587-23-000004 | 021-497891 | 231428667 | 33 | 12534 | ||
| 2023-08-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001534122-23-000008 | 021-489365 | 231158843 | 33 | 12525 | ||
| 2022-10-25 | D | xslFormDX01/primary_doc.xml | 06b | 0001534122-22-000024 | 021-462770 | 221329653 | 33 | 12533 | ||
| 2021-09-13 | D | xslFormDX01/primary_doc.xml | 06b | 0001534122-21-000016 | 021-413136 | 211249365 | 33 | 11673 | ||
| 2021-02-17 | D | xslFormDX01/primary_doc.xml | 06b | 0001534122-21-000003 | 021-389722 | 21644855 | 33 | 11672 | ||
| 2020-09-29 | D | xslFormDX01/primary_doc.xml | 06b | 0001534122-20-000016 | 021-376541 | 201205505 | 33 | 11444 | ||
| 2020-08-13 | D | xslFormDX01/primary_doc.xml | 06b | 0001534122-20-000015 | 021-373194 | 201099097 | 33 | 11441 | ||
| 2020-04-21 | D | xslFormDX01/primary_doc.xml | 06b | 0001534122-20-000008 | 021-365447 | 20804618 | 33 | 10535 | ||
| 2019-10-08 | D | xslFormDX01/primary_doc.xml | 06b | 0001534122-19-000033 | 021-350596 | 191142474 | 33 | 10804 | ||
| 2018-10-15 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001534122-18-000030 | 021-323532 | 181121767 | 33 | 9394 | ||
| 2018-10-15 | D | xslFormDX01/primary_doc.xml | 06b | 0001534122-18-000029 | 021-323532 | 181121727 | 33 | 9284 | ||
| 2017-11-24 | D | xslFormDX01/primary_doc.xml | 06b | 0001534122-17-000035 | 021-299449 | 171221323 | 33 | 8189 |
One latest value per concept from companyfacts (101 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 22.67M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| ifrs-full | AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment | AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment | USD | 1.04M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets | AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets | USD | 399,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | Assets | Assets | USD | 47.66M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| ifrs-full | CashAndCashEquivalents | CashAndCashEquivalents | USD | 23.02M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| ifrs-full | DisposalsPropertyPlantAndEquipment | DisposalsPropertyPlantAndEquipment | USD | 431,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | GeneralAndAdministrativeExpense | GeneralAndAdministrativeExpense | USD | 4.93M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | GrossProfit | GrossProfit | USD | 20.48M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | IncreaseDecreaseInRightofuseAssets | IncreaseDecreaseInRightofuseAssets | USD | -85,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | IncreaseDecreaseThroughOtherChangesRightofuseAssets | IncreaseDecreaseThroughOtherChangesRightofuseAssets | USD | 228,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | InterestExpenseOnOtherFinancialLiabilities | InterestExpenseOnOtherFinancialLiabilities | USD | 5.54M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | InterestIncomeOnDeposits | InterestIncomeOnDeposits | USD | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | InterestIncomeOnOtherFinancialAssets | InterestIncomeOnOtherFinancialAssets | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| ifrs-full | LeaseLiabilities | LeaseLiabilities | USD | 1.41M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| ifrs-full | ProceedsFromIssuingOtherEquityInstruments | ProceedsFromIssuingOtherEquityInstruments | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | ProfitLoss | ProfitLoss | USD | -11.13M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | ResearchAndDevelopmentExpense | ResearchAndDevelopmentExpense | USD | 5.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| ifrs-full | RightofuseAssets | RightofuseAssets | USD | 8.41M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| ifrs-full | SellingExpense | SellingExpense | USD | 15.81M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 2.17M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.63M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 1.98M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 386,000 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 2.18M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 133.00M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 601,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 30.50M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | AssetsNoncurrent | Assets, Noncurrent | USD | 17.16M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 23.02M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 23.02M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 20.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations | USD | 39,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | ConversionOfStockSharesConverted1 | Conversion of Stock, Shares Converted | shares | 2.94M | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | ConvertibleDebtCurrent | Convertible Debt, Current | USD | 0 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 14.03M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | DebtConversionOriginalDebtAmount1 | Debt Conversion, Original Debt, Amount | USD | 7.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | DeferredIncome | Deferred Income | USD | 492,000 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.62M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 0 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.6 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensationNoncash | Employee Benefit and Share-based Payment Arrangement, Noncash | USD | 597,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 10.13M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -11.06M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 39,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -76,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 865,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | IncreaseDecreaseInDeferredLiabilities | Increase (Decrease) in Deferred Liabilities | USD | -415,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 904,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | 482,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | 240,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | InventoryNet | Inventory, Net | USD | 4.56M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 47.66M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 7.68M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | LiabilitiesNoncurrent | Liabilities, Noncurrent | USD | 14.53M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 30.19M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -2.37M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -7.23M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -11.13M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest | USD | -12.91M | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | NotesAndLoansReceivableNetCurrent | Financing Receivable, after Allowance for Credit Loss, Current | USD | 935,000 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | pure | 2 | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 26.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -5.58M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 8.41M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 452,000 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 1.98M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 5.54M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 54,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | OtherSignificantNoncashTransactionValueOfConsiderationGiven1 | Other Significant Noncash Transaction, Value of Consideration Given | USD | 399,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | OtherSignificantNoncashTransactionValueOfConsiderationReceived1 | Other Significant Noncash Transaction, Value of Consideration Received | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 2.35M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 18.26M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | ProceedsFromOtherDebt | Proceeds from Other Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | ProceedsFromRepaymentsOfOtherDebt | Proceeds from (Repayments of) Other Debt | USD | 12.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 36,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 6.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 10.51M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 8.33M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | ReclassificationsOfTemporaryToPermanentEquity | Reclassifications of Temporary to Permanent Equity | USD | 934,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | RepaymentsOfOtherDebt | Repayments of Other Debt | USD | 1.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 433,000 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -107.55M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | Revenues | Revenues | USD | 34.51M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 17.33M | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 | |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 149,000 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | StockGrantedDuringPeriodValueSharebasedCompensation | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | USD | 601,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 25.45M | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 1.33M | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 603,904 | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 106,132 | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments | Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | USD | 20.53M | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 16,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 4.33M | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 2.30M | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 408,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 40-F | 2025-03-31 | 0001376474-25-000299 |
| us-gaap | WeightedAverageNumberOfSharesIssuedBasic | Weighted Average Number of Shares Issued, Basic | shares | 18.41M | 2025-01-01 | 2025-12-31 | 2025 | FY | 40-F | 2026-03-31 | 0001376474-26-000257 |